Gender-Based Differences by Age Range in Patients Hospitalized with COVID-19: A Spanish Observational Cohort Study
- PMID: 33668766
- PMCID: PMC7956359
- DOI: 10.3390/jcm10050899
Gender-Based Differences by Age Range in Patients Hospitalized with COVID-19: A Spanish Observational Cohort Study
Abstract
There is some evidence that male gender could have a negative impact on the prognosis and severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The aim of the present study was to compare the characteristics of coronavirus disease 2019 (COVID-19) between hospitalized men and women with confirmed SARS-CoV-2 infection. This multicenter, retrospective, observational study is based on the SEMI-COVID-19 Registry. We analyzed the differences between men and women for a wide variety of demographic, clinical, and treatment variables, and the sex distribution of the reported COVID-19 deaths, as well as intensive care unit (ICU) admission by age subgroups. This work analyzed 12,063 patients (56.8% men). The women in our study were older than the men, on average (67.9 vs. 65.7 years; p < 001). Bilateral condensation was more frequent among men than women (31.8% vs. 29.9%; p = 0.007). The men needed non-invasive and invasive mechanical ventilation more frequently (5.6% vs. 3.6%, p < 0.001, and 7.9% vs. 4.8%, p < 0.001, respectively). The most prevalent complication was acute respiratory distress syndrome, with severe cases in 19.9% of men (p < 0.001). In men, intensive care unit admission was more frequent (10% vs. 6.1%; p < 0.001) and the mortality rate was higher (23.1% vs. 18.9%; p < 0.001). Regarding mortality, the differences by gender were statistically significant in the age groups from 55 years to 89 years of age. A multivariate analysis showed that female sex was significantly and independently associated with a lower risk of mortality in our study. Male sex appears to be related to worse progress in COVID-19 patients and is an independent prognostic factor for mortality. In order to fully understand its prognostic impact, other factors associated with sex must be considered.
Keywords: COVID-19; SARS-CoV-2; Spain; coronavirus; gender differences.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.Am J Emerg Med. 2021 Jul;45:156-161. doi: 10.1016/j.ajem.2020.08.005. Epub 2020 Aug 16. Am J Emerg Med. 2021. PMID: 33046317 Free PMC article.
-
Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic.Lancet Reg Health Am. 2022 Apr;8:100177. doi: 10.1016/j.lana.2021.100177. Epub 2022 Jan 7. Lancet Reg Health Am. 2022. PMID: 35018359 Free PMC article.
-
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9. Trials. 2020. PMID: 33115543 Free PMC article.
-
Clinical and Epidemiological Features of SARS-CoV-2 Patients in SARI Ward of a Tertiary Care Centre in New Delhi.J Assoc Physicians India. 2020 Jul;68(7):19-26. J Assoc Physicians India. 2020. PMID: 32602676
-
Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit.JAMA Netw Open. 2020 Jun 1;3(6):e2012270. doi: 10.1001/jamanetworkopen.2020.12270. JAMA Netw Open. 2020. PMID: 32543702 Free PMC article. Review.
Cited by
-
Sex Differences and Predictors of In-Hospital Mortality among Patients with COVID-19: Results from the ANCOHVID Multicentre Study.Int J Environ Res Public Health. 2021 Aug 26;18(17):9018. doi: 10.3390/ijerph18179018. Int J Environ Res Public Health. 2021. PMID: 34501608 Free PMC article.
-
Chronic Oral Anticoagulation and Clinical Outcome in Hospitalized COVID-19 Patients.Cardiovasc Drugs Ther. 2022 Aug;36(4):705-712. doi: 10.1007/s10557-021-07194-y. Epub 2021 May 14. Cardiovasc Drugs Ther. 2022. PMID: 33988835 Free PMC article.
-
Risk Factors for COVID-19 Morbidity and Mortality in Institutionalised Elderly People.Int J Environ Res Public Health. 2021 Sep 28;18(19):10221. doi: 10.3390/ijerph181910221. Int J Environ Res Public Health. 2021. PMID: 34639522 Free PMC article.
-
A national population-based study of mortality and risk factors in COVID-19-hospitalized patients in Spain (2020-2021).Front Public Health. 2025 Feb 4;13:1488283. doi: 10.3389/fpubh.2025.1488283. eCollection 2025. Front Public Health. 2025. PMID: 39980912 Free PMC article.
-
Aprotinin treatment against SARS-CoV-2: A randomized phase III study to evaluate the safety and efficacy of a pan-protease inhibitor for moderate COVID-19.Eur J Clin Invest. 2022 Jun;52(6):e13776. doi: 10.1111/eci.13776. Epub 2022 Apr 5. Eur J Clin Invest. 2022. PMID: 35342931 Free PMC article. Clinical Trial.
References
-
- World Health Organization WHO Coronavirus Disease (COVID-19) Dashboard. [(accessed on 15 January 2021)];2020 Available online: https://covid19.who.int/
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous